As we found the reduced mRNA levels of matrix metalloproteinase (MMP) 2 and MMP9 in tumor tissues from LNCaP xenografts injected with GV1001 [22], we further assessed both mRNA and protein expressions of MMP2 and MMP9 in LNCaP cells exposed to vehicle or GV1001. This evidence concerns the gene MMP9 and neoplasm.